Silodosin: all 40 studies that test it

Page 1 of 1. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.

• A Multicenter Randomized Cross-Over Study Evaluating the Efficacy and Safety of Silodosin in Adult Women With Voiding DysfunctionNot yet recruitingNCT07822113Phase 2
• Pupil Size and Choroidal Thickness Changes With Tamsulosin vs. Silodosin in Benign Prostatic Hyperplasia PatientsNot yet recruitingNCT07743060Phase 4
• Iris Structural Changes With Tamsulosin vs. Silodosin in Benign Prostatic Hyperplasia PatientsNot yet recruitingNCT07743034Phase 4
• Tamsulosin Dose Escalation or Silodosin Switch Before Trial Without Catheter in BPH-Related Acute Urinary RetentionRecruitingNCT07650968Phase 4
• Silodosin for Urinary Symptoms in Female Patients With Multiple SclerosisRecruitingNCT07614321Phase 4
• Silodosin vs Tamsulosin for LUTS Due to BPH: A Randomized Crossover TrialNot yet recruitingNCT07467343Phase 4
• Silodosin vs Placebo in the Treatment of Female LUTSNot yet recruitingNCT06114979Phase 3
• Silodosin Versus Tamsulosin for Treatment of Ureteral StonesTerminatedNCT02369744Phase 4Results posted
• Study of Silodosin to Facilitate Passage of Urinary StonesCompletedNCT01144949Phase 2Results posted
• A Study of Silodosin 8 mg Daily for the Treatment of Nocturia in Men With Benign Prostatic HyperplasiaCompletedNCT00793819Phase 2Results posted
• Use of Silodosin to Treat Moderate to Severe Abacterial Chronic Prostatitis/Chronic Pelvic Pain Syndrome.CompletedNCT00740779Phase 2Results posted
• The Evaluation of the Safety of a New Drug for Benign Prostatic Hyperplasia Used for 9 MonthsCompletedNCT00224133Phase 3Results posted
• A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With PlaceboCompletedNCT00224120Phase 3Results posted
• A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With PlaceboCompletedNCT00224107Phase 3Results posted
• The Efficacy and Safety of Qianweitai (Silodosin Capsule) Versus Tamsulosin in the Treatment of BPHCompletedNCT07134907Phase 4
• Comparison of Silodosin and Tamsulosin for Medical Expulsive Therapy in Patients With Ureteral StonesCompletedNCT06999135Not applicable
• Silodosin in Management of Lower Ureteral StonesCompletedNCT06381206Phase 1/2
• The Additive Value of Pyridostigmine to Silodosin in Acute Urinary RetentionCompletedNCT06319469Phase 2
• The Changes of Urine Growth Factors LevelCompletedNCT06282731Early Phase 1
• Silodosin in Retrograde Intrarenal SurgeryCompletedNCT05921370Phase 3
• Double J Stenting and Sildosin After URSL for Lower Ureteric StonesCompletedNCT05823662Not applicable
• Pre-Op Sildosine and Ureteral Dilation During F-URSCompletedNCT05798572Not applicable
• COMPARISON OF SILODOSIN AND TAMSULOSIN IN MEDICAL EXPULSIVE THERAPY OF DISTAL URETERIC CALCULICompletedNCT05790902Phase 1
• Silodosin, Tadalafil Alone vs. Silodosin Plus Tadalafil as MET for Lower Ureteric StonesCompletedNCT05789732Not applicable
• Silodosin vs Tamsulosin as METStatus unknownNCT05570084Phase 3
• The Efficacy and Safety of Silodosin in the Treatment of Benign Prostatic HyperplasiaCompletedNCT05551221Phase 4
• Efficacy of Silodosin in the Treatment of Symptomatic Benign Prostatic Hyperplasia (BPH)CompletedNCT04107896Phase 4
• Safety and Efficacy of Silodosin in the Treatment of Premature EjaculationStatus unknownNCT02581826Phase 2
• Comparative Study of Use of Alpha-Blockers to Treat Symptoms in Prostate Cancer Patients Undergoing Radiation TherapyCompletedNCT02220829Phase 3
• Efficacy and Safety of Silodosin on Nocturia for Patients With Benign Prostatic HyperplasiaCompletedNCT02106182Phase 4
• Effectiveness of Silodosin in Medical Expulsive Therapy for Ureteral Pelvic Stone From 4 to 10 mm.TerminatedNCT02090439Phase 3
• Effectiveness and Safety of Silodosin in the Treatment of Benign Prostatic HyperplasiaCompletedNCT01757769Phase 4
• Differential Effect of Silodosin Versus Tamsulosin on Stone Clearance After Extra-corporeal Shock Wave LithotripsyWithdrawnNCT01560091Phase 3
• A Dose-finding Study of Silodosin in Patients With Urinary CalculiCompletedNCT01539265Phase 2
• Efficacy and Safety of Silodosin in the Treatment of Natural Expulsion in Patients With Ureteral StonesCompletedNCT01533389Phase 4
• Safety and Efficacy of QD Versus BID Silodosin With Lower Urinary Tract Symptoms Suggestive of BPHCompletedNCT01260129Phase 4
• Study of a α1A Adrenoceptor Selective Antagonist Silodosin to Treat Severe Benign Prostatic Hyperplasia(BPH)CompletedNCT01259531Phase 4
• Efficacy and Safety of Silodosin on Voiding Dysfunction Associated With Neurogenic BladderCompletedNCT01228370Phase 4
• A Comparative Study of KSO-0400 in BPH Patients With LUTSCompletedNCT01222650Phase 2
• Evaluation of the Efficacy and Safety of Silodosin in the Treatment of the Signs and Symptoms of BPHCompletedNCT00359905Phase 3

← Silodosin overview